March 17, 2021 Comments Off on New patent for Azurity drug QBRELIS Posted in: Patent Added Annual Drug Patent Expirations for QBRELIS Qbrelis is a drug marketed by Azurity and is included in one NDA. It is available from one supplier. There are six patents protecting…
The post New patent for Azurity drug QBRELIS appeared first on DrugPatentW…
March 17, 2021 Comments Off on New patent for Daiichi Sankyo drug SAVAYSA Posted in: Patent Added Annual Drug Patent Expirations for SAVAYSA Savaysa is a drug marketed by Daiichi Sankyo Inc and is included in one NDA. It is available from one supplier. There are two…
The post New patent for Daiichi Sankyo drug SAVAYSA appeared first on DrugPatentWa…
